Galactose Supplementation for the Treatment of MOGHE

NAUnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

September 1, 2021

Study Completion Date

October 1, 2021

Conditions

Refractory EpilepsySLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation

Interventions

DIETARY_SUPPLEMENT

D-Galactose

Galactose supplementation, once per day, up to 1.5g/kg per day

Trial Locations (1)

RECRUITING

Hospital Ruber Internacional, Madrid